Treatment and prevention of cerebrovascular disorders in children

Current Treatment Options in Neurology

Volumn 7, Issue 6, 2005, Pages 469-480

  Lynch, John Kylan ^a   Pavlakis, Steven ^a   deVeber, Gabrielle ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ALLOPURINOL; ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; CYCLOPHOSPHAMIDE; ENOXAPARIN; FIBRINOLYTIC AGENT; HEPARIN; HYDROXYUREA; IMMUNOSUPPRESSIVE AGENT; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; REVIPARIN; STEROID; TICLOPIDINE; TISSUE PLASMINOGEN ACTIVATOR; VITAMIN; WARFARIN;

ARTERY DISEASE; ARTIFICIAL EMBOLISM; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD PRESSURE REGULATION; BRAIN ANGIOGRAPHY; BRAIN DECOMPRESSION; BRAIN HEMORRHAGE; BRAIN VEIN; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHILD; CLINICAL TRIAL; COHORT ANALYSIS; CONSENSUS DEVELOPMENT; COST EFFECTIVENESS ANALYSIS; CRANIECTOMY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG CONTRAINDICATION; EXCHANGE BLOOD TRANSFUSION; FIBRINOLYTIC THERAPY; GASTROINTESTINAL TOXICITY; HEART DISEASE; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFECTION; INTRACRANIAL HYPERTENSION; LONG TERM CARE; METABOLIC DISORDER; MORBIDITY; MORTALITY; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIMARY PREVENTION; RADIOSURGERY; RECURRENCE RISK; REVIEW; REYE SYNDROME; RISK ASSESSMENT; RISK FACTOR; SECONDARY PREVENTION; SEIZURE; SICKLE CELL ANEMIA; THROMBOCYTOPENIA; TISSUE NECROSIS; TRANSIENT ISCHEMIC ATTACK; TREATMENT INDICATION; VASCULITIS;

EID: 28044442738     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-005-0047-6     Document Type: Review

References (90)

1. Schoenberg BS, Mellinger JF, Schoenberg DG: Cerebrovascular disease in infants and children: a study of incidence, clinical features, and survival. Neurology 1978, 28:763-768.
2. Earley CJ, Kittner SJ, Feeser BR, et al.: Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology 1998, 51:169-176.
3. Giroud M, Lemesle M, Gouyon JB, et al.: Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993. J Clin Epidemiol 1995, 48:1343-1348.
4. Zahuranec DB, Brown DL, Lisabeth LD, Morgenstern LB: Is it time for a large, collaborative study of pediatric stroke? Stroke 2005, 36:1825-1829.
5. Paediatric Stroke Working Group. Stroke in childhood: clinical guidelines for diagnosis, management and rehabilitation. London: Royal College of Physicians of London; 2004.
6. Monagle P, Chan A, Massicotte P, et al.: Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004, 126:645S-687S.
7. Ganesan V, Prengler M, McShane MA, et al.: Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol 2003, 53:167-173.
8. Kumar K: Neurological complications of congenital heart disease. Indian J Pediatr 2000, 67:S15-S19.
9. Chabrier S, Husson B, Lasjaunias P, et al.: Stroke in childhood: outcome and recurrence risk by mechanism in 59 patients. J Child Neurol 2000, 15:290-294.
10. Sebire G, Fullerton H, Riou E, deVeber G: Toward the definition of cerebral arteriopathies of childhood. Curr Opin Pediatr 2004, 16:617-622.
11. Fullerton HJ, Johnston SC, Smith WS: Arterial dissection and stroke in children. Neurology 2001, 57:1155-1160.
12. McKusick VA: Online Mendelian inheritance in man. OMIM 2004.
13. Horn P, Pfister S, Bueltmann E, et al.: Moyamoya-like vasculopathy (moyamoya syndrome) in children. Childs Nerv Syst 2004, 20:382-391.
14. Scothorn DJ, Price C, Schwartz D, et al.: Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr 2002, 140:348-354.
15. Powars D, Wilson B, Imbus C, et al.: The natural history of stroke in sickle cell disease. Am J Med 1978, 65:461-471.
16. Buchanan GR, DeBaun MR, Quinn CT, Steinberg MH: Sickle cell disease. Hematology 2004, 9:35-47.
17. Hoppe C, Klitz W, Cheng S, et al.: Gene interactions and stroke risk in children with sickle cell anemia. Blood 2004, 103:2391-2396.
18. Adams RJ: Stroke prevention and treatment in sickle cell disease. Arch Neurol 2001, 58:565-568.
19. Kirkham FJ, Prengler M, Hewes DK, Ganesan V: Risk factors for arterial ischemic stroke in children. J Child Neurol 2000, 15:299-307.
20. Steen RG, Emudianughe T, Hankins GM, et al.: Brain imaging findings in pediatric patients with sickle cell disease. Radiology 2003, 228:216-225.
21. Akar N, Akar E, Deda G, et al.: Factor V1691 G-A, prothrombin 20210 G-A, and methylenetetrahydrofolate reductase 677 C-T variants in Turkish children with cerebral infarct. J Child Neurol 1999, 14:749-751.
22. Kenet G, Sadetzki S, Murad H, et al.: Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000, 31:1283-1288.
23. Nowak-Gottl U, Strater R, Heinecke A, et al.: Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999, 94:3678-3682.
24. Hagstrom JN, Walter J, Bluebond-Langner R, et al.: Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease. J Pediatr 1998, 133:777-781.
25. Bonduel M, Sciuccati G, Hepner M, et al.: Factor V Leiden and prothrombin gene G20210A mutation in children with cerebral thromboembolism. Am J Hematol 2003, 73:81-86.
26. McColl MD, Chalmers EA, Thomas A, et al.: Factor V Leiden, prothrombin 20210G-->A and the MTHFR C677T mutations in childhood stroke. Thromb Haemost 1999, 81:690-694.
27. Zenz W, Bodo Z, Plotho J, et al.: Factor V Leiden and prothrombin gene G 20210 A variant in children with ischemic stroke. Thromb Haemost 1998, 80:763-766.
28. Strater R, Becker S, von Eckardstein A, et al.: Prospective assessment of risk factors for recurrent stroke during childhood - a 5-year follow-up study. Lancet 2002, 360:1540-1545.
29. Lanthier S, Carmant L, David M, et al.: Stroke in children: the coexistence of multiple risk factors predicts poor outcome. Neurology 2000, 54:371-378.
30. Lindsberg PJ, Grau AJ: Inflammation and infections as risk factors for ischemic stroke. Stroke 2003, 34:2518-2532.
31. Snyder RD, Stovring J, Cushing AH, et al.: Cerebral infarction in childhood bacterial meningitis. J Neurol Neurosurg Psychiatr 1981, 44:581-585.
32. Narayan P, Samuels OB, Barrow DL: Stroke and pediatric human immunodeficiency virus infection. Case report and review of the literature. Pediatr Neurosurg 2002, 37:158-163.
33. Guidi B, Bergonzini P, Crisi G, et al.: Case of stroke in a 7-year-old male after parvovirus B19 infection. Pediatr Neurol 2003, 28:69-71.
34. Bell ML, Buchhalter JR: Influenza A-associated stroke in a 4-year-old male. Pediatr Neurol 2004, 31:56-58.
35. Sebire G, Meyer L, Chabrier S: Varicella as a risk factor for cerebral infarction in childhood: a case-control study. Ann Neurol 1999, 45:679-680.
36. Ichiyama T, Houdou S, Kisa T, et al.: Varicella with delayed hemiplegia. Pediatr Neurol 1990, 6:279-281.
37. Askalan R, Laughlin S, Mayank S, et al.: Chickenpox and stroke in childhood: a study of frequency and causation. Stroke 2001, 32:1257-1262.
38. Lynch JK: Cerebrovascular disorders in children. Curr Neurol Neurosci Rep 2004, 4:129-138.
39. Barnes C, deVeber G: Prothrombotic abnormalities in childhood ischaemic stroke. Thromb Res 2005, In press.
40. deVeber G, Monagle P, Chan A, et al.: Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol 1998, 55:1539-1543.
41. Heller C, Heinecke A, Junker R, et al.: Cerebral venous thrombosis in children: a multifactorial origin. Circulation 2003, 108:1362-1367.
42. Muthukumar N: Uncommon cause of sinus thrombosis following closed mild head injury in a child. Childs Nerv Syst 2004, 21:86-88.
43. Sousa J, O'Brien D, Bartlett R, Vaz J: Sigmoid sinus thrombosis in a child after closed head injury. Br J Neurosurg 2004, 18:187-188.
44. Stiefel D, Eich G, Sacher P: Posttraumatic dural sinus thrombosis in children. Eur J Pediatr Surg 2000, 10:41-44.
45. Huisman TA, Holzmann D, Martin E, Willi UV: Cerebral venous thrombosis in childhood. Eur Radiol 2001, 11:1760-1765.
46. Al Jarallah A, Al Rifai MT, Riela AR, Roach ES: Nontraumatic brain hemorrhage in children: etiology and presentation. J Child Neurol 2000, 15:284-289.
47. Di Rocco C, Tamburrini G, Rollo M: Cerebral arteriovenous malformations in children. Acta Neurochir (Wien) 2000, 142:145-156.
48. Eeg-Olofsson O, Ringheim Y: Stroke in children. Clinical characteristics and prognosis. Acta Paediatr Scand 1983, 72:391-395.
49. Punt J: Surgical management of paediatric stroke. Pediatr Radiol 2004, 34:16-23.
50. Meyer-Heim AD, Boltshauser E: Spontaneous intracranial haemorrhage in children: aetiology, presentation and outcome. Brain Dev 2003, 25:416-421.
51. Chung B, Wong V: Pediatric stroke among Hong Kong Chinese subjects. Pediatrics 2004, 114:e206-e212.
52. Butros LJ, Bussel JB: Intracranial hemorrhage in immune thrombocytopenic purpura: a retrospective analysis. J Pediatr Hematol Oncol 2003, 25:660-664.
53. Laurent JP, Bruce DA, Schut L: Hemorrhagic brain tumors in pediatric patients. Childs Brain 1981, 8:263-270.
54. Broderick J, Talbot GT, Prenger E, et al.: Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol 1993, 8:250-255.
55. Roach ES, Riela AR: Pediatric Cerebrovascular Disorders, edn 2. Armonk, NY: Futura Publishing Company; 1995.
56. Hutchison JS, Ichord R, Guerguerian AM, deVeber G: Cerebrovascular disorders. Semin Pediatr Neurol 2004, 11:139-146.
57. Adelson PD, Bratton SL, Carney NA, et al.: Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents. Chapter 8. Cerebral perfusion pressure. Pediatr Crit Care Med 2003, 4:S31-S33.
58. Capes SE, Hunt D, Malmberg K, et al.: Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001, 32:2426-2432.
59. Wirrell EC, Armstrong EA, Osman LD, Yager JY: Prolonged seizures exacerbate perinatal hypoxic-ischemic brain damage. Pediatr Res 2001, 50:445-454.
60. Thirumalai SS, Shubin RA: Successful treatment for stroke in a child using recombinant tissue plasminogen activator. J Child Neurol 2000, 15:558.
61. Noser EA, Felberg RA, Alexandrov AV: Thrombolytic therapy in an adolescent ischemic stroke. J Child Neurol 2001, 16:286-288.
62. Golomb MR, Rafay M, Armstrong D, et al.: Intra-arterial tissue plasminogen activator for thrombosis complicating cerebral angiography in a 17-year-old girl. J Child Neurol 2003, 18:420-423.
63. Younkin DP: Diagnosis and treatment of ischemic pediatric stroke. Curr Neurol Neurosci Rep 2002, 2:18-24.
64. Wang M, Hays T, Balasa V, et al.: Low-dose tissue plasminogen activator thrombolysis in children. J Pediatr Hematol Oncol 2003, 25:379-386.
65. Adams HP Jr, Adams RJ, Brott T, et al.: Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003, 34:1056-1083.
66. Leaker M, Massicotte MP, Brooker LA, Andrew M: Thrombolytic therapy in pediatric patients: a comprehensive review of the literature. Thromb Haemost 1996, 76:132-134.
67. Gabis LV, Yangala R, Lenn NJ: Time lag to diagnosis of stroke in children. Pediatrics 2002, 110:924-928.
68. Andrew M, Marzinotto V, Massicotte P, et al.: Heparin therapy in pediatric patients: a prospective cohort study. Pediatr Res 1994, 35:78-83.
69. Massicotte P, Adams M, Marzinotto V, et al.: Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose finding study. J Pediatr 1996, 128:313-318.
70. Strater R, Kurnik K, Heller C, et al.: Aspirin versus low-dose low-molecular-weight heparin: antithrombotic therapy in pediatric ischemic stroke patients: a prospective follow-up study. Stroke 2001, 32:2554-2558.
71. Hune S, Rafay MF, Domi T, et al.: Plavix (clopidogrel) in pediatric stroke: monitoring of side effects and patient education strategies [abstract]. Stroke 2004, 35:284.
72. Lee MC, Frank JI, Kahana M, et al.: Decompressive hemicraniectomy in a 6-year-old male after unilateral hemispheric stroke. Case report and review. Pediatr Neurosurg 2003, 38:181-185.
73. deVeber G, Chan A, Monagle P, et al.: Anticoagulation therapy in pediatric patients with sinovenous thrombosis: a cohort study. Arch Neurol 1998, 55:1533-1537.
74. Dix D, Andrew M, Marzinotto V, et al.: The use of low molecular weight heparin in pediatric patients: a prospective cohort study. J Pediatr 2000, 136:439-445.
75. Streif W, Mitchell LG, Andrew M: Antithrombotic therapy in children. Curr Opin Pediatr 1999, 11:56-64.
76. deVeber G, Andrew M, Canadian Pediatric Ischemic Stroke Study Group: Cerebral sinovenous thrombosis in children. N Engl J Med 2001, 345:417-423.
77. Shroff M, deVeber G: Sinovenous thrombosis in children. Neuroimaging Clin N Am 2003, 13:115-138.
78. Canhao P, Falcao F, Ferro JM: Thrombolytics for cerebral sinus thrombosis: a systematic review. Cerebrovasc Dis 2003, 15:159-166.
79. Broderick JP, Adams HP Jr, Barsan W, et al.: Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999, 30:905-915.
80. Smith ER, Butler WE, Ogilvy CS: Surgical approaches to vascular anomalies of the child's brain. Curr Opin Neurol 2002, 15:165-171.
81. Adams RJ, McKie VC, Hsu L, et al.: Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998, 339:5-11.
82. NHLBI Communications Office: NHLBI Stops Study Testing How Long Children with Sickle Cell Anemia Should Have Blood Transfusions to Prevent Stroke. Washington, DC: 2004.
83. Clancy RR, McGaurn SA, Goin JE, et al.: Allopurinol neurocardiac protection trial in infants undergoing heart surgery using deep hypothermic circulatory arrest. Pediatrics 2001, 108:61-70.
84. Houkin K, Kuroda S, Nakayama N: Cerebral revascularization for moyamoya disease in children. Neurosurg Clin N Am 2001, 12:575-584, ix.
85. Fung LW, Thompson D, Ganesan V: Revascularisation surgery for paediatric moyamoya: a review of the literature. Childs Nerv Syst 2005, 21:358-364.
86. Bonduel M, Hepner M, Sciuccati G, et al.: Prothrombotic disorders in children with moyamoya syndrome. Stroke 2001, 32:1786-1792.
87. Andrew M, Monagle PT, Brooker L: Thromboembolic Complications During Infancy and Childhood, edn 1. Hamilton, Ontario: B.C. Decker Inc.; 2000.
88. Wang WC, Kovnar EH, Tonkin IL, et al.: High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. J Pediatr 1991, 118:377-382.
89. Sumoza A, de Bisotti R, Sumoza D, Fairbanks V: Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA). Am J Hematol 2002, 71:161-165.
90. National Institutes of Health: Bone Marrow Transplantation in Treating Children with Sickle Cell Disease. Washington, DC: 1999.